For instance, miR-124-3p.1 sensitizes the response of HCC cells to sorafenib by regulating FOXO3a levels through targeting AKT2 and SIRT1 [20], and miR-221-3p targets LIFR to regulates HCC cell performance [21]. This evidence concerns the gene SIRT1 and hepatocellular carcinoma.